QCOM vs RNAC · P/E 16, rev $44.28B vs P/E 2.1, rev $38.9M
Qualcomm Incorporated (QCOM) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
QCOM currently screens at market cap $175.02B and trailing P/E 16.3. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the QCOM and RNAC stock pages for the full models.
Not investment advice.